Quarterly report · Q2

Period2022-01-01 → 2022-06-30
Filed2022-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥840m2022-01-01 → 2022-06-30Cons.Net sales
Revenue¥2.0bn2021-01-01 → 2021-12-31Cons.Net sales (5-year summary)
Revenue¥430m2021-01-01 → 2021-06-30Cons.Net sales
Operating income−¥312m2022-01-01 → 2022-06-30Cons.Operating income
Operating income−¥777m2021-01-01 → 2021-06-30Cons.Operating income
Ordinary income−¥306m2022-01-01 → 2022-06-30Cons.Ordinary income
Ordinary income−¥523m2021-01-01 → 2021-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥775m2021-01-01 → 2021-06-30Cons.Ordinary income
Profit before tax−¥349m2022-01-01 → 2022-06-30Cons.Income before income taxes
Profit before tax−¥781m2021-01-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)−¥359m2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥534m2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥776m2021-01-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income−¥359m2022-01-01 → 2022-06-30Cons.Profit loss
Net income−¥776m2021-01-01 → 2021-06-30Cons.Profit loss
Total assets¥5.2bnat 2022-06-30Cons.Assets
Total assets¥5.4bnat 2021-12-31Cons.Assets
Total assets¥3.7bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥792mat 2022-06-30Cons.Liabilities
Total liabilities¥1.1bnat 2021-12-31Cons.Liabilities
Net assets / equity¥4.4bnat 2022-06-30Cons.Net assets
Net assets / equity¥4.3bnat 2021-12-31Cons.Net assets
Net assets / equity¥3.1bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥4.7bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥3.8bnat 2021-12-31Cons.Cash and deposits
Cash & equivalents¥4.7bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥3.8bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥3.2bnat 2021-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.3bnat 2020-12-31dCons.Cash and cash equivalents
Operating cash flow¥585m2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥1.5bn2021-01-01 → 2021-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥963m2021-01-01 → 2021-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥57m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥42m2021-01-01 → 2021-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥34m2021-01-01 → 2021-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥166m2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
Financing cash flow¥1.1bn2021-01-01 → 2021-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥102m2021-01-01 → 2021-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-26.532022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-25.252022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-42.12021-01-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-62.562021-01-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-39.462021-04-01 → 2021-06-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio84.7%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio79.3%at 2021-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio84.5%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥286m
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥286m
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥547m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥553m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥553m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥235m
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentsegment profit2021-01-01 → 2021-06-30−¥922m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue2021-01-01 → 2021-06-30¥430m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue external2021-01-01 → 2021-06-30¥430m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentsegment profit2021-01-01 → 2021-06-30¥145m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 439
ItemContextValueUnit
Impairment loss elPrior1YTDDuration6108000JPY
Impairment loss elCurrentYTDDuration42948000JPY
Extraordinary lossPrior1YTDDuration6108000JPY
Extraordinary lossCurrentYTDDuration42948000JPY
Income before income taxesPrior1YTDDuration-780840000JPY
Income before income taxesCurrentYTDDuration-349379000JPY
Income taxes currentPrior1YTDDuration1371000JPY
Income taxes currentCurrentYTDDuration9802000JPY
Income taxes deferredPrior1YTDDuration-5739000JPY
Income taxes deferredCurrentYTDDuration-61000JPY
Income taxesPrior1YTDDuration-4367000JPY
Income taxesCurrentYTDDuration9740000JPY
Profit lossPrior1YTDDuration-776472000JPY
Profit lossCurrentYTDDuration-359120000JPY
Profit loss attributable to owners of parentPrior1YTDDuration-776472000JPY
Profit loss attributable to owners of parentCurrentYTDDuration-359120000JPY
Profit lossPrior1YTDDuration-776472000JPY
Profit lossCurrentYTDDuration-359120000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-292000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-1241000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration1963000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration87600000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration9221000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration36662000JPY
Other comprehensive incomePrior1YTDDuration10892000JPY
Other comprehensive incomeCurrentYTDDuration123021000JPY
Comprehensive incomePrior1YTDDuration-765579000JPY
Comprehensive incomeCurrentYTDDuration-236098000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration-765579000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration-236098000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-JPY
Income before income taxesPrior1YTDDuration-780840000JPY
Income before income taxesCurrentYTDDuration-349379000JPY
Depreciation and amortization ope cfPrior1YTDDuration9079000JPY
Depreciation and amortization ope cfCurrentYTDDuration13604000JPY
Impairment loss ope cfPrior1YTDDuration6108000JPY
Impairment loss ope cfCurrentYTDDuration42948000JPY
Interest income ope cfPrior1YTDDuration-57000JPY
Interest income ope cfCurrentYTDDuration-57000JPY
Dividends income ope cfPrior1YTDDuration-198000JPY
Dividends income ope cfCurrentYTDDuration-204000JPY
Interest expenses ope cfPrior1YTDDuration2194000JPY
Interest expenses ope cfCurrentYTDDuration3063000JPY
Share based compensation expenses ope cfPrior1YTDDuration29565000JPY
Share based compensation expenses ope cfCurrentYTDDuration24205000JPY
Subsidy income ope cfPrior1YTDDuration-7200000JPY
Subsidy income ope cfCurrentYTDDuration-JPY
Stock issuance cost ope cfPrior1YTDDuration208000JPY
Stock issuance cost ope cfCurrentYTDDuration1434000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2021-12-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-12-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-01-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass